Pharmesis International Ltd. provided earnings guidance for the six months and full year ended 31 December 2023. For the period, Group is expected to report a net loss for the condensed interim financial statements for the six months and full year ended 31 December 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 SGD | -5.41% | -5.41% | +7.14% |
1st Jan change | Capi. | |
---|---|---|
+7.14% | 2.14M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- BFK Stock
- News Pharmesis International Ltd.
- Pharmesis International Ltd. Provides Earnings Guidance for the Six Months and Full Year Ended 31 December 2023